top of page

Generating Evidence for Diagnosis & Therapy of RarE LIVEr Disease: the RELIVE Initiative...

  • Writer: Nicholas Murtha
    Nicholas Murtha
  • Jun 21, 2021
  • 1 min read

Updated: Jan 14, 2022

Generating Evidence for Diagnosis and Therapy of RarE LIVEr Disease: the RELIVE Initiative for Systematic Reviews and Meta-Analyses


Article Category: Position Statement


Abstract: RELIVE is a multidisciplinary project to establish evidence-based therapies for rare liver diseases. Systematic reviews and meta-analyses will be the starting point for a structured development of guidelines for rare conditions of the liver. The novel approach will be the integration of case reports and small series of patients with specific rare liver disease. A vital resource of information and data will be used, that has been largely neglected so far. Pooling of several different, presumably similar conditions within one study will be avoided. Thus, a major step towards evidence-based therapies for orphan liver diseases will be achieved.






Comments


©2021 by Liver Surgery Research HD.

bottom of page